The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis/Ipsen; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - Boehringer Ingelheim; Roche
3rd-line anaplastic lymphoma kinase (ALK) inhibitors (ALKi) in advanced non-small cell lung cancer (aNSCLC): Real-world comparison to non-ALKi therapy.
 
Natalie Maimon
No Relationships to Disclose
 
Elizabeth Dudnik
No Relationships to Disclose
 
Yakir Rottenberg
Consulting or Advisory Role - Dexcel Pharma; MSD
Speakers' Bureau - AstraZeneca; Medison; MSD; Roche
Research Funding - AstraZeneca; MSD
Patents, Royalties, Other Intellectual Property - Name: BIOACTIVE PHENOL METAL COMPLEXES Provisional Patent 62/834,717 filed in 16/04/2019 (Yissum Ref. No. 6607-00) Inventor: Abraham Jacob DombPI, Noam SteinmanPI, Yakir RottenbergC Stage: provisional (no country designation yet) Status: commercialized
Travel, Accommodations, Expenses - Astellas Pharma; Teva
 
Noa Popovits-Hadari
No Relationships to Disclose
 
Noam Asna
No Relationships to Disclose
 
Mira Wollner
Honoraria - AstraZeneca; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche Israel (Inst); takeda
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche Israel
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer
 
Alona Zer
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Maya Gottfried
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Moshe Mishaeli
Consulting or Advisory Role - Boehringer Ingelheim; MSD; Takeda
 
Yulia Rovitsky-Gelis
No Relationships to Disclose
 
Anastasiya Lobachov
No Relationships to Disclose
 
Amir Onn
Honoraria - Boehringer Ingelheim; MSD; Roche
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca
 
Damien Urban
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche; Takeda
Consulting or Advisory Role - Merck Sharp & Dohme; Roche Israel; Takeda; Teva
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Sharp & Dohme; Takeda
 
Mor Tal Moskovitz
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; MSD; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Takeda
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer
 
Jair Bar
Honoraria - Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche/Genentech; Takeda
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)